Deep Analysis of Impact of COVID-19 on “Cerebral Spinal Fluid Management Market 2019-2025” Growth Worldwide….
The global cerebral spinal fluid (CSF) management
market size is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View
Research, Inc. Constant evaluation of various techniques by neurosurgeons for
improvement of hydrocephalus management is expected to drive growth in this
market. Moreover, shunt manufacturers are engaged in the investment for
development of novel and improved shunts in order to tackle the pitfalls
associated with the existing designs.
With Covid-19
infections rising globally, the apprehension regarding a shortage of essential
life-saving devices and other essential medical supplies in order to prevent
the spread of this pandemic and provide optimum care to the infected also
widens. In addition, till a pharmacological treatment is developed, ventilators
act as a vital treatment preference for the COVID-19 patients, who may require
critical care. Moreover, there is an urgent need for a rapid acceleration in
the manufacturing process for a wide range of test-kits (antibody tests,
self-administered, and others). The report will account for Covid19 as a key
market contributor.
Significant increase in geriatric population across the
globe as well as raise in incidence of chronic CNS associated disorders such as
stroke can be attributed to projected growth. Furthermore, grants for research
in neuromodulation therapies in order to develop different products for
prognosis of various nervous system associated disorders are expected to boost
development.
The global
cerebral spinal fluid management market size was valued at USD 879.1 million in
2014 and is projected to witness lucrative growth year on year growth. Unique
nature of cerebrospinal fluid dynamics in each patient has challenged
neurologists, neurosurgeons, and medical device developers. This has led to
increasing demand for advanced cerebral spinal fluid (CSF) management devices.
To Request Sample Copy of this report, click the link:
Further Key Findings from the Study Suggest:
·
CSF management devices are expected to
witness extensive competition owing to presence of several market players
operating in this segment. Rise in number of CSF associated disorders such as
trauma and stroke are anticipated to boost demand for these products in the
coming years.
·
Cerebral spinal fluid
management shunts captured the largest market share in terms of revenue
generation in 2014.
·
These devices are most commonly used for
supplementing and replacing lost drainage capacity in case of CSF leak
management.
·
CSF drainage is anticipated to witness
lucrative growth over the forecast period.
·
This growth can be attributed to ongoing
development for enhancing overall safety of guidance-based systems and
anti-biotic impregnated catheters incorporation.
·
In 2014, North America accounted for the
largest share with respect to revenue generation.
·
Factors contributive for the share include
continuous increase in the number of Americans affected from Hydrocephalus
coupled with ongoing research in neuroscience.
·
Asia Pacific is expected to propel with
fastest CAGR owing to constantly improving healthcare system in the region.
·
Moreover, economic progress of Asia Pacific
countries such as China has led to significant transformation of neurology and
neurologic practices in the country. This is one of the key drivers to propel
progress in this region in the coming years.
·
Some of the key players operating in the
cerebrospinal fluid management market include Johnson & Johnson Services,
Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra
LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH
& Co. KG; and Beckersmith Medical, Inc.
·
These players are engaged in development of
novel platforms for CSF management.
Rapid
advancements in ongoing research projects related to brain barriers and brain
fluids are anticipated to impact the market growth to a large extent. These
research projects are mainly aimed at management of hydrocephalus and other
cerebro-spinal fluid associated disorders.
These products have attracted a significant amount of
attention owing to the potential prospects of the application in the treatment
of hydrocephalus and other brain associated disorders. This is primarily
attributable to the lack of proper treatment for such diseases, which prompts
the neurologist to invest for the development of these products.
According to Hydrocephalus Association, nearly 700,000 older
Americans are estimated to live with normal pressure hydrocephalus. Moreover, it
is observed that one to two out of every 1,000 babies are born with this
condition. Presence of such large population base suffering with the disease is
expected to drive demand of these products and platforms.
Furthermore, conferences and workshops on basic science
research and its translation into diagnosis and treatment of cerebrospinal
fluid disorders are expected to propagate the growth in this segment of
neurology devices. These conferences are intended to increase awareness amongst
neurosurgeon, nurse practitioners, and physicians about current treatment
options for such disorders and for the advancements in these options.
Have any Query? Ask our Experts:
Grand View Research has segmented the
global cerebral spinal fluid management market on the basis of products and
region:
CSF Management Product Outlook (Revenue,
USD Million, 2012 - 2022)
·
CSF shunts
·
CSF drainage
CSF Management Regional Outlook (Revenue,
USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment